The project “Biological Pathways and Next-Generation Imaging Features Predicting Prostate Cancer Progression in Active Surveillance”, coordinated by Dr. Giorgio Gandaglia, a researcher at URI and the Vita-Salute San Raffaele University, has received the My First AIRC Grant (MFAG24) funding. This study aims to identify biological mechanisms and innovative imaging-based biomarkers to improve the selection of low-risk prostate cancer patients suitable for active surveillance. Through the integration of innovative methods including genomics, spatial transcriptomics, immunohistochemistry, and PET/MRI imaging with PSMA, the goal is to develop a predictive model to personalize treatments, reduce unnecessary biopsies, and customize the care pathway.
Dr. Giorgio Gandaglia
Urologist at the Urology Unit of the IRCCS Ospedale San Raffaele
Coordinator of the prostate cancer group of the Young Academic Urologists Working Parties of the EAU
